•
Dec 31, 2021
Zomedica Q4 2021 Earnings Report
Reported consolidated financial results for the year ended December 31, 2021.
Key Takeaways
Zomedica's total revenue for the Fourth Quarter 2021 was $4.1 million, with PulseVet contributing $4.0 million, a 66% increase over the previous year. The company ended the year with $195 million in cash and cash equivalents.
TRUFORMA® product revenue grew to $73,000 in Q4 2021, a 224% increase over Q3 2021.
PulseVet revenue grew to $4.0 million in Q4 2021, a 66% increase over Q4 2020.
Total revenue for Q4 2021 was $4.1 million, compared to $0 in 2020, with a gross margin of 73.9%.
Zomedica ended the year with cash and cash equivalents of $195 million.